Company: SNSE
Filing Date: 2025-04-01
Form Type: PRE 14A
Source: 0000950170-25-048533
Chunk: 55

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-01
Form: PRE 14A
Chunk 55
---
,609 |

Amounts reported represent the aggregate grant date fair value of equity awards granted to our directors during 2024 under our 2021 Plan, computed in accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the awards reported in this column are set forth in the notes to our audited consolidated financial statements included in our Form 10-K, filed with the SEC on March 28, 2025. These amounts do not reflect the actual economic value that may be realized by the non-employee director.

As of December 31, 2024, Mr. Ringo held 2,978 RSUs.

Represents an option to purchase 19,000 shares of our common stock granted on June 10, 2024 at an exercise price of $0.71 per share. As of December 31, 2024, Dr. English, Mr. Holmen, Mr. Humer, Dr. Peyer, Mr. Ringo, Mr. Ricks and Dr. Vojta held options to purchase 44,554, 89,995, 64,767, 67,620, 62,650, 67,620 and 38,600 shares of our common stock, respectively.

Non-Employee Director Compensation Policy

Following recommendation from the compensation committee, in March 2024 our Board of Directors amended our non-employee director compensation policy (the "2024 Amended Policy").

Under the 2024 Amended Policy, each non-employee director receives cash compensation as follows:

|                                                                                        |     | Annual Cash Retainer ($) |        |
| Annual retainer                                                                        |     |                          | 35,000 |
| Additional retainer for independent chair                                              |     |                          | 35,000 |
| Additional retainer for audit committee chair                                          |     |                          | 15,000 |
| Additional retainer for audit committee non-chair member                               |     |                          |  7,500 |
| Additional retainer for compensation committee chair                                   |     |                          | 10,000 |
| Additional retainer for compensation committee non-chair member                        |     |                          |  5,000 |
| Additional retainer for nominating and corporate governance committee chair            |     |                          |  8,000 |
| Additional retainer for nominating and corporate governance committee non-chair member |     |                          |  4,000 |
| Additional retainer for science and technology committee chair (1)                     |